Get started

MRNA

MRNA going back down to $120?As mentioned in my last analysis, Monday will be the deal-breaker for MRNA again, and it failed to hold that resistance. Using historic data this will most likely drop down to $120 again before going back up to the $130s so this can be a great swing trade. BUT! Watch out for support at $126, using the previous downward channel trend resistance this can act as support so watch out for that. Reasons for bearishness: -Historic data of the resistance and dip (influenced the most) -EMA's crossing right now -RSI was oversold It's a clear bearish sign that probably won't last for long so look for a nice swing trade here. (I am not a financial advisor)
NASDAQ:MRNAShort
by Geckie
MRNA Moderna vs PFE Pfizer | Head and Shoulders patternIf you haven`t longed Moderna with me from here: Then you should realize that the head an shoulders pattern on descending volume of a company that worth 53.402B, but has 747Mil negative earnings for 2020, may lead to $100 per share. On the other hand, undervalued, it`s Pfizer , which has the same amazing results with the vaccine, lots of medicine in the portfolio, a market cap almost 4 times higher, 198.973B and positive earnings of 9.62Bil. The pay also great dividends, btw, 4.38% DIV YIELD on a decent 20.82 P/E ratio . If you are interested to test some amazing BUY and SELL INDICATORS which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
NASDAQ:MRNAShort
by TopgOptions
8
MRNA Upside PotentialModerna has been forming a hidden bullish divergence for the past 5 months (clearly seen on the daily chart, will also post a screenshot in the comments). On the macro-level, we can see a pennant forming with strongly confirmed resistance and support. On the micro-level, we have a clear cup and handle, and currently the price seats at the support of the handle, in 3h demand, and also at a strong key level 135-136, that MRNA always reacted to in the past. If Moderna confirms the cup and handle by breaking the resistance, would love to add to my long position. However, if it can not hold 135-136, will look to exit and reenter at the macro support ~129. *The idea above is my own opinion and does not serve as any kind of investment advice. Please do your own due diligence.*
NASDAQ:MRNALong
by CodrinTrades
4
MRNA to 250 in MarMRNA could possibly reach as high as 250’s before or after the earnings report on 10 Mar. Not only it may beat the earnings estimate, there are also quite positive news which may lead to explosive growth. First-in-human clinical trial confirms novel HIV vaccine approach developed by IAVI and Scripps Research NEW YORK and LA JOLLA, CA—A phase 1 clinical trial testing a novel vaccine approach to prevent HIV has produced promising results, IAVI and Scripps Research announced today. The vaccine showed success in stimulating production of rare immune cells needed to start the process of generating antibodies against the fast-mutating virus; the targeted response was detected in 97 percent of participants who received the vaccine. … The study sets the stage for additional clinical trials that will seek to refine and extend the approach—with the long-term goal of creating a safe and effective HIV vaccine. As a next step, IAVI and Scripps Research are partnering with the biotechnology company Moderna to develop and test an mRNA-based vaccine that harnesses the approach to produce the same beneficial immune cells. Using mRNA technology could significantly accelerate the pace of HIV vaccine development. … The strategy of targeting naïve B cells with specific properties is called “germline-targeting,” as these young B cells display antibodies encoded by unmutated, or “germline” genes. Researchers believe the approach could also be applied to vaccines for other challenging pathogens such as influenza, dengue, Zika, hepatitis C viruses and malaria.
NASDAQ:MRNALong
by financialSnail88674
6
Don’t follow the INSIDERS, THEY KNOW NOTHING ABOUT STOCKS!While MRNA has had a great year and rewarded its investors by decent +1500% profit in a year! Checking the fact that insiders have sold 29,554,776 share in 300 trades last year and bought 310,142 shares will shock you..! Interestingly, they bought 0 share in last 3 months, when they have had the result of their COVID-19 vaccine which is 95% effective..! No need to say that MRNA stock had almost 180% gain ever since !
NASDAQ:MRNAEducation
by Moshkelgosha
1/26 WATCHLISTif there is any indication that we are definitely in the final leg of a bull market, today was it. Everything was pumping euphorically at open across the board until the market showed us what a mid-euphoric pullback could look like, with the rug being pulled right from under us. A lot of names like TSLA did bounce back after, but it reminds us that its SUPER IMPORTANT to stay cautious in this environment. I am still bullish in the short term. 1/26 WATCHLIST My trading style is intraday option trading - these are not swing levels. MRNA calls over 147.5 BYND calls over 164.15 BYND played out perfectly from the watchlist I posted yesterday. It has a bit more room to go to the next supply at 168.25 and then 171 - let's see if it can keep the momentum up tomorrow AI calls over 151/152 massive move today. 152 was a support level in December that has turned into resistance that AI has been trying to beat for a month. TSLA calls over 887 or 900 MSFT calls over 230.2 or 233 Would like to see more tight consolidation underneath these levels but something to keep an eye on for the near future. BTBT calls over 19
NASDAQ:MRNALong
by algrowithm